Ciprofloxacin

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
46001
Oral empirical therapy of fever in low-risk neutropenic cancer patients : a prospective, double-blind, randomized, multicenter trial comparing monotherapy (single daily dose Moxifloxacin) with combination therapy (Ciprofloxacin plus Amoxicillin/Clavulanic acid)

Back to Protocol section